- £49.26m
- £52.32m
- $29.49m
- 46
- 18
- 92
- 50
REG - Tissue Regenix Group - Exercise of Options and Total Voting Rights
AnnouncementREG - Tissue Regenix Group - Notice of interim results
AnnouncementREG - Tissue Regenix Group - Half-Year Trading Update
AnnouncementREG - Tissue Regenix Group - Distribution agreement for OrthoPure® XT in the UK
AnnouncementREG - Tissue Regenix Group - Distribution agreement with Australian Allografts
AnnouncementREG - Tissue Regenix Group - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 28/04/2023
AnnouncementREG - Tissue Regenix Group - Result of AGM, Share Reorganisation &TVR
AnnouncementREG - Tissue Regenix Group - Proposed Share Reorganisation Timetable
AnnouncementREG - Tissue Regenix Group - CEO and CFO Share Purchases
AnnouncementREG - Tissue Regenix Group - Holding(s) in Company
AnnouncementREG - Tissue Regenix Group - Final results for the year ended 31 December 2022
AnnouncementREG - Tissue Regenix Group - Notice of results and Investor presentation
AnnouncementREG - Tissue Regenix Group - Trading update for 2022
AnnouncementREG - Tissue Regenix Group - Change of Adviser
AnnouncementREG - Tissue Regenix Group - Holding(s) in Company
AnnouncementREG - Tissue Regenix Group - Chinese distribution agreement for OrthoPure® XT
AnnouncementREG - Tissue Regenix Group - Product launch in dCELL® division
AnnouncementREG - Tissue Regenix Group - Distribution agreement - OrthoPure® XT in Germany
Announcement